PharmaPoint: Hepatitis C Virus - Current and Future Players

Publisher Name :
Date: 31-May-2013
No. of pages: 64
Inquire Before Buying

Summary

GlobalData has released its pharma report, “PharmaPoint: Hepatitis C Virus - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HCV Market. The report identifies and analyses the key companies shaping and driving the global HCV market. The report provides insight into the competitive HCV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope


  • Investigation of current and future market competition for HCV

  • Competitor assessment

  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

  • Strategic assessment of the HCV sector through market impact analysis, future market scenario and company analysis


Reasons to buy

  • Gain a high level view of the trends shaping and driving the HCV Market

  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

  • What’s the next big thing in the global HCV market landscape? Identify, understand and capitalize

PharmaPoint: Hepatitis C Virus - Current and Future Players

Table Of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
2.3 Upcoming Related Reports 11

3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16

4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 23
4.3 Company Profiles 24
4.3.1 Merck 24
4.3.2 Roche 26
4.3.3 Vertex 28
4.3.4 Janssen 29
4.3.5 Gilead 31
4.3.6 AbbVie 34
4.3.7 Bristol-Myers Squibb 36
4.3.8 Boehringer Ingelheim 38
4.4 Additional Companies with Promising Drugs 40
4.4.1 Mitsubishi Tanabe 40
4.4.2 GlaxoSmithKline 41
4.4.3 Achillion 41
4.4.4 Scynexis 42
4.4.5 Idenix 43
4.4.6 Presidio 44

5 Appendix 45
5.1 Bibliography 45
5.2 Abbreviations 48
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Percent Drug-Treated Patients 49
5.4.2 Patient Warehousing 50
5.4.3 Drugs Included in Each Therapeutic Class 50
5.4.4 Launch and Patent Expiry Dates 51
5.4.5 General Pricing Assumptions 52
5.4.6 Individual Drug Assumptions 52
5.4.7 Generic Erosion 55
5.4.8 Selection of Pipeline Agents 55
5.4.9 Pricing of Pipeline Agents 56
5.5 Physicians and Specialists Included in this Study 59
5.6 Survey of Prescribing Physicians 61
5.7 About the Authors 62
5.7.1 Author 62
5.7.2 Epidemiologist 62
5.7.3 Global Head of Healthcare 63
5.8 About GlobalData 64
5.9 Contact Us 64
5.10 Disclaimer 64

List Of Tables

Table 1: Global Sales Forecasts ($m) for HCV, 2012–2022 14
Table 2: HCV Market – Drivers and Barriers, 2013 16
Table 3: Key Companies in the HCV Market, 2012 22
Table 4: Merck’s HCV Portfolio Assessment, 2012 25
Table 5: Merck SWOT Analysis, 2012 25
Table 6: Roche’s HCV Portfolio Assessment, 2012 27
Table 7: Roche SWOT Analysis, 2012 27
Table 8: Vertex’s HCV Portfolio Assessment, 2012 28
Table 9: Vertex SWOT Analysis, 2012 29
Table 10: Janssen’s HCV Portfolio Assessment, 2012 30
Table 11: Janssen SWOT Analysis, 2012 31
Table 12: Gilead’s HCV Portfolio Assessment, 2012 33
Table 13: Gilead SWOT Analysis, 2012 33
Table 14: AbbVie’s HCV Portfolio Assessment, 2012 35
Table 15: AbbVie SWOT Analysis, 2012 35
Table 16: Bristol-Myers Squibb’s HCV Portfolio Assessment, 2012 37
Table 17: Bristol-Myers Squibb SWOT Analysis, 2012 37
Table 18: Boehringer Ingelheim’s HCV Portfolio Assessment, 2012 39
Table 19: Boehringer Ingelheim SWOT Analysis, 2012 39
Table 20: Mitsubishi Tanabe’s HCV Portfolio Assessment, 2012 40
Table 21: GlaxoSmithKline’s HCV Portfolio Assessment, 2012 41
Table 22: Achillion’s HCV Portfolio Assessment, 2012 42
Table 23: Scynexis’ HCV Portfolio Assessment, 2012 42
Table 24: Idenix’s HCV Portfolio Assessment, 2012 43
Table 25: Presidio’s HCV Portfolio Assessment, 2012 44
Table 26: Key Launch Dates 51
Table 27: Key Patent Expiries 51
Table 28: Physicians Surveyed, By Country 61

List of Figures

Figure 1: Global Sales for HCV Therapeutics by Region, 2012–2022 15
Figure 2: Company Portfolio Gap Analysis in HCV, 2012–2022 22

  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Global Hepatitis Vaccines Sales Market Report 2021
    Published: 23-Aug-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Hepatitis Vaccines Revenue, means the sales value of Hepatitis Vaccines This report studies sales (consumption) of Hepatitis Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GlaxoSmithKline - Sanofi Pasteur - Merck......
  • Global Hepatitis A Vaccine Sales Market Report 2021
    Published: 05-Aug-2016        Price: US 4000 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Hepatitis A Vaccine Revenue, means the sales value of Hepatitis A Vaccine This report studies sales (consumption) of Hepatitis A Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering GlaxoSmithKline MERCK SHARP & DOHME COR......
  • Global Human Hepatitis B Immunoglobulin (IM) Consumption 2016 Market Research Report
    Published: 14-Jul-2016        Price: US 4000 Onwards        Pages: 172
    The Global Human Hepatitis B Immunoglobulin (IM) Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Human Hepatitis B Immunoglobulin (IM) market. First, the report provides a basic overview of the Human Hepatitis B Immunoglobulin (IM) industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.......
  • Global Human Hepatitis B Immunoglobulin (IM) Industry 2016 Market Research Report
    Published: 07-Jul-2016        Price: US 2800 Onwards        Pages: 158
    The Global Human Hepatitis B Immunoglobulin (IM) Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Human Hepatitis B Immunoglobulin (IM) industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human Hepatitis B Immunoglobulin (IM) market analysis is provided for the international market including development history, competitive......
  • Global Hepatitis A Vaccine Industry 2016 Market Research Report
    Published: 06-Jul-2016        Price: US 2800 Onwards        Pages: 152
    The Global Hepatitis A Vaccine Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Hepatitis A Vaccine industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis A Vaccine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development st......
  • United States Alcoholic Hepatitis Drugs Industry 2016 Market Research Report
    Published: 06-Jul-2016        Price: US 3800 Onwards        Pages: 137
    The United States Alcoholic Hepatitis Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Alcoholic Hepatitis Drugs industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Alcoholic Hepatitis Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions d......
  • Global Hepatitis Partnering 2010 to 2016
    Published: 01-Jul-2016        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access t- the hepatitis partnering deals and agreements entered int- by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partnering deal......
  • Global Alcoholic Hepatitis Drugs Consumption 2016 Market Research Report
    Published: 28-Jun-2016        Price: US 4000 Onwards        Pages: 159
    The Global Alcoholic Hepatitis Drugs Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Alcoholic Hepatitis Drugs market. First, the report provides a basic overview of the Alcoholic Hepatitis Drugs industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report......
  • China Hepatitis B Vaccine Industry 2016 Market Research Report
    Published: 23-Jun-2016        Price: US 3200 Onwards        Pages: 138
    The China Hepatitis B Vaccine Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Hepatitis B Vaccine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hepatitis B Vaccine market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status. ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs